on Affluent Medical (isin : FR0013333077)
Carvolix: Share capital and voting rights as of September 30, 2026
Carvolix, a company listed on Euronext Paris under the code FR0013333077, has announced the composition of its share capital and the total number of voting rights as of September 30, 2026. The company has a share capital of 6,227,838.40 euros, divided into 62,278,384 shares.
The total number of theoretical voting rights is 90,255,136, while the exercisable voting rights amount to 90,204,904. These figures meet the transparency requirements, in accordance with the regulations of the Financial Markets Authority.
Based in Aix-en-Provence, Carvolix is a company specializing in the development of advanced medical technologies, with an ambition focused on the treatment of structural heart diseases.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Affluent Medical news